As of 2024-12-14, the Relative Valuation of MacroGenics Inc (MGNX) is (28.85) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.40 USD, the upside of MacroGenics Inc based on Relative Valuation is -948.6%.
The range of the Relative Valuation is (29.74) - (43.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.4x - 27.9x | 17.5x |
| Forward P/E multiples | 19.1x - 31.6x | 19.6x |
| Fair Price | (29.74) - (43.37) | (28.85) |
| Upside | -974.7% - -1375.4% | -948.6% |
| Date | P/E |
| 2024-12-11 | -2.19 |
| 2024-12-10 | -2.15 |
| 2024-12-09 | -2.24 |
| 2024-12-06 | -2.25 |
| 2024-12-05 | -2.18 |
| 2024-12-04 | -2.24 |
| 2024-12-03 | -2.21 |
| 2024-12-02 | -2.37 |
| 2024-11-29 | -2.31 |
| 2024-11-27 | -2.34 |
| 2024-11-26 | -2.19 |
| 2024-11-25 | -2.12 |
| 2024-11-22 | -2.08 |
| 2024-11-21 | -2.06 |
| 2024-11-20 | -2.11 |
| 2024-11-19 | -2.24 |
| 2024-11-18 | -2.26 |
| 2024-11-15 | -2.30 |
| 2024-11-14 | -2.45 |
| 2024-11-13 | -2.42 |
| 2024-11-12 | -2.64 |
| 2024-11-11 | -2.82 |
| 2024-11-08 | -2.80 |
| 2024-11-07 | -2.87 |
| 2024-11-06 | -2.69 |
| 2024-11-05 | -2.42 |
| 2024-11-04 | -2.38 |
| 2024-11-01 | -2.49 |
| 2024-10-31 | -2.35 |
| 2024-10-30 | -2.19 |
| 2024-10-29 | -2.15 |
| 2024-10-28 | -2.26 |
| 2024-10-25 | -2.24 |
| 2024-10-24 | -2.31 |
| 2024-10-23 | -2.53 |
| 2024-10-22 | -2.51 |
| 2024-10-21 | -2.48 |
| 2024-10-18 | -2.58 |
| 2024-10-17 | -2.58 |
| 2024-10-16 | -2.65 |
| 2024-10-15 | -2.56 |
| 2024-10-14 | -2.75 |
| 2024-10-11 | -2.66 |
| 2024-10-10 | -2.40 |
| 2024-10-09 | -2.35 |
| 2024-10-08 | -2.33 |
| 2024-10-07 | -2.31 |
| 2024-10-04 | -2.31 |
| 2024-10-03 | -2.28 |
| 2024-10-02 | -2.27 |